scholarly article | Q13442814 |
P356 | DOI | 10.1159/000099200 |
P698 | PubMed publication ID | 17310106 |
P2093 | author name string | Heather A Drummond | |
David E Stec | |||
Kimberly P Gannon | |||
Janis S Beaird | |||
P2860 | cites work | Inhibitors of cytochrome P450 4A suppress angiogenic responses | Q35083648 |
Evidence for a membrane site of action for 14,15-EET on expression of aromatase in vascular smooth muscle | Q44183007 | ||
P433 | issue | 1-4 | |
P304 | page(s) | 121-128 | |
P577 | publication date | 2007-01-01 | |
P1433 | published in | Cellular Physiology and Biochemistry | Q2229420 |
P1476 | title | 20-Hydroxyeicosatetraenoic acid (20-HETE) stimulates migration of vascular smooth muscle cells | |
P478 | volume | 19 |
Q28288942 | 20-HETE and blood pressure regulation: clinical implications |
Q35991539 | 20-HETE contributes to ischemia-induced angiogenesis |
Q90503328 | 20-HETE in the regulation of vascular and cardiac function |
Q37142503 | 20-HETE induces remodeling of renal resistance arteries independent of blood pressure elevation in hypertension |
Q36902591 | 20-HETE-induced mitochondrial superoxide production and inflammatory phenotype in vascular smooth muscle is prevented by glucose-6-phosphate dehydrogenase inhibition |
Q34343723 | 20-Hydroxyeicosatetraenoic acid inhibition attenuates balloon injury-induced neointima formation and vascular remodeling in rat carotid arteries |
Q33574917 | 20-hydroxy-5,8,11,14-eicosatetraenoic acid mediates endothelial dysfunction via IkappaB kinase-dependent endothelial nitric-oxide synthase uncoupling |
Q28571898 | Angiotensin II-induced vascular smooth muscle cell migration and growth are mediated by cytochrome P450 1B1-dependent superoxide generation |
Q92512924 | CYP1B1: A key regulator of redox homeostasis |
Q89051959 | Conflicting roles of 20-HETE in hypertension and renal end organ damage |
Q36744134 | Cyclooxygenase-2 dependent metabolism of 20-HETE increases adiposity and adipocyte enlargement in mesenchymal stem cell-derived adipocytes |
Q34157216 | Cytochrome P450 1B1 contributes to angiotensin II-induced hypertension and associated pathophysiology |
Q28396302 | Cytochrome P450 eicosanoids and cerebral vascular function |
Q34152658 | Cytochrome P450 ω-hydroxylase promotes angiogenesis and metastasis by upregulation of VEGF and MMP-9 in non-small cell lung cancer |
Q44362268 | Differential expression of cytochrome P450 omega-hydroxylase isoforms and their association with clinicopathological features in pancreatic ductal adenocarcinoma. |
Q42115749 | Induction of angiotensin-converting enzyme and activation of the renin-angiotensin system contribute to 20-hydroxyeicosatetraenoic acid-mediated endothelial dysfunction. |
Q37138134 | Intravenous formulation of N-hydroxy-N'-(4-n-butyl-2-methylphenyl)formamidine (HET0016) for inhibition of rat brain 20-hydroxyeicosatetraenoic acid formation |
Q35787438 | Involvement of cytochrome P-450 1B1 in renal dysfunction, injury, and inflammation associated with angiotensin II-induced hypertension in rats |
Q39000644 | Microsomal cytochrome P450 as a target for drug discovery and repurposing |
Q37340856 | Molecular mechanisms and cell signaling of 20-hydroxyeicosatetraenoic acid in vascular pathophysiology |
Q37439758 | Rapid, simultaneous quantitation of mono and dioxygenated metabolites of arachidonic acid in human CSF and rat brain |
Q38100223 | Role of cytochrome P450-mediated arachidonic acid metabolites in the pathogenesis of cardiac hypertrophy. |
Q34338086 | Targeting 20-HETE producing enzymes in cancer - rationale, pharmacology, and clinical potential |
Search more.